Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Plos One
|
January 22, 2011
Ralstonia solanacearum extracellular polysaccharide is a specific elicitor of defense responses in wilt-resistant tomato plants
Annett Milling, Lavanya Babujee, Caitilyn Allen
Applied and Environmental Microbiology
|
March 15, 2015
Tropical strains of Ralstonia solanacearum Outcompete race 3 biovar 2 strains at lowland tropical temperatures
Alejandra I Huerta, Annett Milling, Caitilyn Allen
Applied and Environmental Microbiology
|
September 21, 2010
Moderate temperature fluctuations rapidly reduce the viability of Ralstonia solanacearum race 3, biovar 2, in infected geranium, tomato, and potato plants
Jacob M Scherf, Annett Milling, Caitilyn Allen
Phytopathology
|
September 11, 2009
Interactions with hosts at cool temperatures, not cold tolerance, explain the unique epidemiology of Ralstonia solanacearum race 3 biovar 2
Annett Milling, Fanhong Meng, Timothy P Denny, et al.
Mbio
|
July 19, 2012
The in planta transcriptome of Ralstonia solanacearum: conserved physiological and virulence strategies during bacterial wilt of tomato
Jonathan M Jacobs, Lavanya Babujee, Fanhong Meng, et al.
Chemotherapy
|
October 24, 2007
High-dose platinum combination therapy in pretreated patients with disseminated melanoma
Maja A Hofmann, Verena Gabriel, Annett Milling, et al.
Plant Disease
|
January 29, 2019
Sensitive, Secure Detection of Race 3 Biovar 2 and Native U.S. Strains of Ralstonia solanacearum
Tuan Minh Tran, Jonathan M Jacobs, Alejandra Huerta, et al.
Mbio
|
November 28, 2013
Ralstonia solanacearum requires PopS, an ancient AvrE-family effector, for virulence and To overcome salicylic acid-mediated defenses during tomato pathogenesis
Jonathan M Jacobs, Annett Milling, Raka M Mitra, et al.
International Journal of Cancer
|
May 18, 2004
Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients
Uwe Trefzer, Gunda Herberth, Karolina Wohlan, et al.
Vaccine
|
March 10, 2005
Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results
Uwe Trefzer, Gunda Herberth, Karolina Wohlan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Plos One
|
January 22, 2011
Ralstonia solanacearum extracellular polysaccharide is a specific elicitor of defense responses in wilt-resistant tomato plants
Annett Milling, Lavanya Babujee, Caitilyn Allen
Applied and Environmental Microbiology
|
March 15, 2015
Tropical strains of Ralstonia solanacearum Outcompete race 3 biovar 2 strains at lowland tropical temperatures
Alejandra I Huerta, Annett Milling, Caitilyn Allen
Applied and Environmental Microbiology
|
September 21, 2010
Moderate temperature fluctuations rapidly reduce the viability of Ralstonia solanacearum race 3, biovar 2, in infected geranium, tomato, and potato plants
Jacob M Scherf, Annett Milling, Caitilyn Allen
Phytopathology
|
September 11, 2009
Interactions with hosts at cool temperatures, not cold tolerance, explain the unique epidemiology of Ralstonia solanacearum race 3 biovar 2
Annett Milling, Fanhong Meng, Timothy P Denny, et al.
Mbio
|
July 19, 2012
The in planta transcriptome of Ralstonia solanacearum: conserved physiological and virulence strategies during bacterial wilt of tomato
Jonathan M Jacobs, Lavanya Babujee, Fanhong Meng, et al.
Chemotherapy
|
October 24, 2007
High-dose platinum combination therapy in pretreated patients with disseminated melanoma
Maja A Hofmann, Verena Gabriel, Annett Milling, et al.
Plant Disease
|
January 29, 2019
Sensitive, Secure Detection of Race 3 Biovar 2 and Native U.S. Strains of Ralstonia solanacearum
Tuan Minh Tran, Jonathan M Jacobs, Alejandra Huerta, et al.
Mbio
|
November 28, 2013
Ralstonia solanacearum requires PopS, an ancient AvrE-family effector, for virulence and To overcome salicylic acid-mediated defenses during tomato pathogenesis
Jonathan M Jacobs, Annett Milling, Raka M Mitra, et al.
International Journal of Cancer
|
May 18, 2004
Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients
Uwe Trefzer, Gunda Herberth, Karolina Wohlan, et al.
Vaccine
|
March 10, 2005
Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results
Uwe Trefzer, Gunda Herberth, Karolina Wohlan, et al.
Page
of 2